K Pharma,Inc. (4896) Ratios

0 Followers

K Pharma,Inc. Ratios

See a summary of JP:4896’s cash flow.

Ratios	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	―	28.41	37.00	18.54	40.70
Quick Ratio	―	28.29	36.91	18.48	40.40
Cash Ratio	―	27.43	35.74	18.30	39.69
Solvency Ratio	―	-0.59	-8.93	1.24	-10.25
Operating Cash Flow Ratio	―	-9.02	-15.50	2.55	-10.79
Short-Term Operating Cash Flow Coverage	―	0.00	0.00	0.00	0.00
Net Current Asset Value	¥ ―	¥ 1.22B	¥ 2.25B	¥ 3.10B	¥ 1.33B
Leverage Ratios
Debt-to-Assets Ratio	―	0.51	0.00	0.00	0.00
Debt-to-Equity Ratio	―	1.19	0.00	0.00	0.00
Debt-to-Capital Ratio	―	0.54	0.00	0.00	0.00
Long-Term Debt-to-Capital Ratio	―	0.54	0.00	0.00	0.00
Financial Leverage Ratio	―	2.32	1.04	1.07	1.03
Debt Service Coverage Ratio	―	-125.67	0.00	27.45	0.00
Interest Coverage Ratio	―	-125.30	0.00	30.89	0.00
Debt to Market Cap	―	0.20	0.00	0.00	0.00
Interest Debt Per Share	―	129.89	0.00	1.02	0.00
Net Debt to EBITDA	―	1.41	2.69	-8.92	3.42
Profitability Margins
Gross Profit Margin	―	0.00%	0.00%	91.00%	0.00%
EBIT Margin	―	0.00%	0.00%	36.61%	0.00%
EBITDA Margin	―	0.00%	0.00%	36.61%	0.00%
Operating Profit Margin	―	0.00%	0.00%	36.61%	0.00%
Pretax Profit Margin	―	0.00%	0.00%	30.11%	0.00%
Net Profit Margin	―	0.00%	0.00%	26.03%	0.00%
Continuous Operations Profit Margin	―	0.00%	0.00%	26.03%	0.00%
Net Income Per EBT	―	100.28%	100.28%	86.47%	100.49%
EBT Per EBIT	―	108.13%	100.93%	82.25%	110.39%
Return on Assets (ROA)	―	-33.79%	-35.97%	7.86%	-28.55%
Return on Equity (ROE)	―	-78.49%	-37.48%	8.38%	-29.37%
Return on Capital Employed (ROCE)	―	-32.28%	-36.53%	11.67%	-26.38%
Return on Invested Capital (ROIC)	―	-32.28%	-36.53%	10.09%	-26.38%
Return on Tangible Assets	―	-33.79%	-35.97%	7.86%	-28.55%
Earnings Yield	―	-12.97%	-11.75%	3.12%	-4.44%
Efficiency Ratios
Receivables Turnover	―	0.00	0.00	0.00	0.00
Payables Turnover	―	0.00	0.00	7.63	0.00
Inventory Turnover	―	0.00	0.00	8.34	0.00
Fixed Asset Turnover	―	0.00	0.00	0.00	0.00
Asset Turnover	―	0.00	0.00	0.30	0.00
Working Capital Turnover Ratio	―	0.00	0.00	0.45	0.00
Cash Conversion Cycle	―	0.00	0.00	-4.06	0.00
Days of Sales Outstanding	―	0.00	0.00	0.00	0.00
Days of Inventory Outstanding	―	0.00	0.00	43.78	0.00
Days of Payables Outstanding	―	0.00	0.00	47.83	0.00
Operating Cycle	―	0.00	0.00	43.78	0.00
Cash Flow Ratios
Operating Cash Flow Per Share	―	-79.10	-84.77	39.16	-38.96
Free Cash Flow Per Share	―	-80.07	-86.02	38.31	-42.17
CapEx Per Share	―	0.96	1.25	0.84	3.21
Free Cash Flow to Operating Cash Flow	―	1.01	1.01	0.98	1.08
Dividend Paid and CapEx Coverage Ratio	―	-82.07	-67.89	46.36	-12.13
Capital Expenditure Coverage Ratio	―	-82.07	-67.89	46.36	-12.13
Operating Cash Flow Coverage Ratio	―	-0.61	0.00	0.00	0.00
Operating Cash Flow to Sales Ratio	―	0.00	0.00	0.45	0.00
Free Cash Flow Yield	―	-12.13%	-13.85%	5.32%	-4.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-7.71	-8.51	32.10	-22.52
Price-to-Sales (P/S) Ratio	―	0.00	0.00	8.36	0.00
Price-to-Book (P/B) Ratio	―	6.05	3.19	2.69	6.61
Price-to-Free Cash Flow (P/FCF) Ratio	―	-8.24	-7.22	18.79	-22.46
Price-to-Operating Cash Flow Ratio	―	-8.34	-7.33	18.39	-24.31
Price-to-Earnings Growth (PEG) Ratio	―	-0.44	0.02	-0.21	-0.20
Price-to-Fair Value	―	6.05	3.19	2.69	6.61
Enterprise Value Multiple	―	-6.95	-5.85	13.90	-19.20
Enterprise Value	―	6.37B	4.94B	5.09B	7.50B
EV to EBITDA	―	-6.95	-5.85	13.90	-19.20
EV to Sales	―	0.00	0.00	5.09	0.00
EV to Free Cash Flow	―	-6.85	-4.95	11.45	-19.06
EV to Operating Cash Flow	―	-6.94	-5.02	11.20	-20.63
Tangible Book Value Per Share	―	109.04	194.60	267.55	143.21
Shareholders’ Equity Per Share	―	109.04	194.60	267.55	143.21
Tax and Other Ratios
Effective Tax Rate	―	>-0.01	>-0.01	0.14	>-0.01
Revenue Per Share	―	0.00	0.00	86.17	0.00
Net Income Per Share	―	-85.59	-72.94	22.43	-42.06
Tax Burden	―	1.00	1.00	0.86	1.00
Interest Burden	―	1.08	1.00	0.82	1.00
Research & Development to Revenue	―	0.00	0.00	0.00	0.00
SG&A to Revenue	―	0.00	0.00	0.00	0.00
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00	0.00
Income Quality	―	0.92	1.17	1.51	0.93

Currency in JPY